Kimura Kiminori, Nagaki Masahito, Nishihira Jun, Satake Shinichi, Kuwata Kazuo, Moriwaki Hisataka
First Department of Internal Medicine, Gifu University School of Medicine, 1-1 Yanagido, Gifu-shi Gifu 501-1194, Japan.
Clin Vaccine Immunol. 2006 Mar;13(3):415-9. doi: 10.1128/CVI.13.3.415-419.2006.
Macrophage migration inhibitory factor (MIF) plays a pivotal role in the development of various inflammatory diseases. Here, we found that anti-mouse MIF antibody treatment reduced liver injury and inflammatory cell infiltration into the liver after injection of antigen-specific cytotoxic T lymphocytes into hepatitis B virus transgenic mice.
巨噬细胞移动抑制因子(MIF)在多种炎症性疾病的发展中起关键作用。在此,我们发现,在将抗原特异性细胞毒性T淋巴细胞注射到乙型肝炎病毒转基因小鼠体内后,抗小鼠MIF抗体治疗减轻了肝脏损伤以及炎性细胞向肝脏的浸润。